Continuing Pharmacy Education / CE Master List / What in the World: A Global Look at Healthcare and Drugs-RECORDED WEBINAR
Please use this button to register in our system as a new user, or to purchase a CE Activity.
For free CE's, returning users can simply click the "TAKE TEST/EVALUATION" button on the right.
Please use this button when you have completed the CE Activity and are ready to take the quiz and complete the evaluation.

What in the World: A Global Look at Healthcare and Drugs-RECORDED WEBINAR

About this Course

This course is a recorded (home study version) of the CE Finale Encore Webinars.

 

Learning Objectives

Upon completion of this application based CE Activity, a pharmacist will be able to:

1.       Describe the key components of global healthcare systems
2.       Discuss the performance indicators of global health systems
3.       Compare pharmaceutical drug spending levels and trends globally
4.       Define medical tourism and analyze its associated risks and benefits

Release and Expiration Dates

Released:  December 16, 2022
Expires:  December 16, 2025

Course Fee

$17 Pharmacist

ACPE UAN

0009-0000-22-055-H04-P

Session Code

22RW55-CBA96

Accreditation Hours

1.0 hours of CE

Additional Information

 

How to Complete Evaluation:  When you are ready to submit quiz answers, go to the BLUE take test/evaluation button.

Accreditation Statement

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs)  for completing the activity ACPE UAN 0009-0000-22-055-H04-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Grant Funding

There is no grant funding for this activity.

Faculty

Bisni Narayanan, PharmD
Outpatient Pharmacy Services
Yale New Haven Health System Pharmacy Supervisor- Operations
Hamden, CT

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

  • Dr. Narayanan has no relationships with ineligible companies

Disclaimer

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Content

Post Test

World Health Post Test – CE Finale

After completing this continuing education activity, pharmacists will be able to
1. Describe the key components of global healthcare systems
2. Discuss the performance indicators of global health systems
3. Compare pharmaceutical drug spending levels and trends globally
4. Define medical tourism and analyze its associated risks and benefits

Which of the following are key components in global health systems?

a. Wait times, patient satisfaction, propensity to result in personal bankruptcy, number of healthcare professionals employed, accreditation

b. Type of ownership (public vs. private), patient’s financial obligations, extent of coverage (e.g., preventive, inpatient, outpatient care, etc.)

c. Antibiotic resistance, risk of exposure to blood borne diseases, long distance travel, exposure to unusual infections

What is a common problem encountered in the universal payer model that is frequently used as a performance measure?

a. High out of pocket cost of care

b. Long wait times

c. Higher mortality rates

In comparison to other high-income countries, where does the U.S system’s administrative efficiency rank?

a. 9th

b. 10th

c. 11th

A student under your supervision is filling a prescription for a newly approved drug. She asks if it is a biologic and you say no, it is a drug (also called a small molecule) and explain the difference between a drug and a biologic, most of which are specialty medications. She says that she heard that long patent lives on innovative drugs fuel pharmaceutical drug spending. What do you tell her?

a. “You are incorrect. The largest contributor to increased spending for pharmaceuticals is specialty medications”

b. “You are incorrect. The largest contributor to increased spending for pharmaceuticals is COVID-19 therapeutics.”

c. “You are incorrect. The largest contributor to increased spending for pharmaceuticals is over the counter medications.”

Handouts

Download

VIDEO